Cellular immunity and hepatitis-associated, Australia antigen liver disease.
暂无分享,去创建一个
[1] D. Rubenstein,et al. New antigen-antibody system in Australia-antigen-positive hepatitis. , 1971, Lancet.
[2] J. Nielsen,et al. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. , 1971, The New England journal of medicine.
[3] G. C. Turner,et al. SH (Australia) antigen in early life , 1971, Archives of disease in childhood.
[4] A. A. Laiwah,et al. Lymphocyte transformation by Australia antigen. , 1971, Lancet.
[5] P. Stastny,et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. , 1971, Lancet.
[6] K. Isselbacher,et al. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. , 1971, The New England journal of medicine.
[7] S. Sherlock,et al. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. , 1971, Lancet.
[8] A. Prince,et al. Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. , 1971, Lancet.
[9] L. Barker,et al. Aquisition of hepatitis-associated antigen. Clinical features in young adults. , 1971, JAMA.
[10] G. Bouvier. The heterogeneity of Australia antigen. , 1971 .
[11] K. Isselbacher,et al. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. , 1970, Lancet.
[12] S. Sherlock,et al. Hepatitis-associated Antigen and Antibody in Haemodialysis Patients and Staff , 1970, British medical journal.
[13] R. Spears,et al. Hepatitis-associated antigen (Australia antigen) in mother and infant. , 1970, The New England journal of medicine.
[14] W. Szmuness,et al. The serum hepatitis virus specific antigen (SH): a preliminary report of epidemiologic studies in an institution for the mentally retarded. , 1970, American journal of epidemiology.
[15] S. Sherlock,et al. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. , 1970, Lancet.
[16] S. Krugman,et al. Viral hepatitis. New light on an old disease. , 1970, JAMA.
[17] L. Barker,et al. Transmission of serum hepatitis. , 1970, JAMA.
[18] A. P. Waterson,et al. Immune complexes in hepatitis. , 1969, Lancet.
[19] R. Wright,et al. Australia antigen in acute and chronic liver disease. , 1969, Lancet.
[20] A. Zuckerman,et al. Persistence of the Serum Hepatitis (SH-Australia) Antigen for Many Years , 1969, Nature.
[21] Larsen Jh. Immunological tolerance and the significance of cell-mediated immunity in virus infections. , 1969 .
[22] M. Oldstone,et al. PATHOGENESIS OF CHRONIC DISEASE ASSOCIATED WITH PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION , 1969, The Journal of experimental medicine.
[23] F. Burnet. Measles as an index of immunological function. , 1968, Lancet.
[24] M. Lechat,et al. Association between lepromatous leprosy and Australia antigen. , 1967, Lancet.
[25] D. Hungerford,et al. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. , 1967, Annals of internal medicine.
[26] J. Sheagren,et al. Impaired delayed hypersensitivity in patients with lepromatous leprosy. , 1966, Lancet.
[27] A. Aisenberg. Studies on delayed hypersensitivity in Hodgkin's disease. , 1962, The Journal of clinical investigation.
[28] A. Sutnick,et al. Australia antigen as a hepatitis virus. Variation in host response. , 1970, The American journal of medicine.
[29] G. Fairley,et al. Cellular resistance to tumours. , 1967, British medical bulletin.
[30] A. Allison. Cell-mediated immune responses to virus infections and virus-induced tumours. , 1967, British medical bulletin.